<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article164</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/IDEAL-ICU" style="display:block; margin-bottom:10px;">IDEAL-ICU Original</a></li>
<h2><strong>IDEAL-ICU</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "Renal-Replacement Therapy in Septic Shock with Acute Kidney Injury". The New England Journal of Medicine. ClinicalTrials.gov number, NCT01682590.<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
In patients with early-stage septic shock and severe acute kidney injury (AKI) without life-threatening complications, does early initiation of renal-replacement therapy within 12 hours offer a mortality benefit over initiation after 48 hours?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
Early initiation of renal-replacement therapy in septic shock patients with severe AKI showed no significant difference in 90-day mortality compared to a strategy in which renal-replacement therapy was delayed for 48 hours.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/><br/>
<br/><br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/><br/>
<br/>
<h2><strong>Design</strong></h2><br/>
Multicenter, randomized, controlled, open-label trial<br/>
N=488 patients with early-stage septic shock and severe AKI<br/>
Early initiation of renal-replacement therapy within 12 hours (n=239)<br/>
Delayed initiation after 48 hours without recovery (n=238)<br/>
Mean follow-up: 90 days<br/>
Primary outcome: All-cause mortality at 90 days<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
Inclusion Criteria: Patients â‰¥18 years old within 48 hours of septic shock and vasopressor therapy onset, with severe AKI classified as "failure" stage by RIFLE criteria<br/>
Exclusion Criteria: Immediate need for emergency renal-replacement therapy before randomization<br/>
Baseline Characteristics: Comparable between both groups concerning demographics and clinical parameters<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
Early strategy: Renal-replacement initiated within 12 hours after AKI documentation<br/>
Delayed strategy: Initiated after 48 hours delay if no spontaneous recovery and no emergency criteria developed<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
Primary Outcome: No significant difference in mortality at 90 days (early: 58%, delayed: 54%, P=0.38)<br/>
Secondary Outcomes: No significant differences in secondary outcomes, including 28-day and 180-day mortality, days free of renal-replacement therapy, and length of stay in ICU or hospital<br/>
<br/>
<h2><strong>Criticisms</strong></h2><br/>
- The adoption of the RIFLE classification which may not be as sensitive as KDIGO classification for identifying patients with AKI.<br/>
- A delayed strategy of only 48 hours may not be long enough to determine clear differences between early and delayed initiation of renal-replacement therapy.<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
The trial was funded by the French Ministry of Health.<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/><p></p>
</div>
</div>
</div>
</div>
</body>
</html>
